Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
about
Cytotoxic T cell immunity against telomerase reverse transcriptase in humansMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsThe transporter associated with antigen processing: function and implications in human diseasesDefective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cellsThe current status of therapeutic HPV vaccineGenetic variants in TAP are associated with high-grade cervical neoplasia.In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC class I in the endoplasmic reticulum.Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigenTumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.Prospects for immunotherapy of malignant disease.Pivotal molecules of MHC I pathway in human primary hepatocellular carcinomaImmunosuppressive tumor microenvironment in cervical cancer patientsLoss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus.Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progressionStable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAPFrequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.Expression of class I MHC molecule, HSP70 and TAP in human hepatocellular carcinomaDownregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residuesSelf antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapyAn immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapyGeneration of CD8+ T cells specific for transporter associated with antigen processing deficient cells.Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.Association of TAP gene polymorphisms and risk of cervical intraepithelial neoplasiaHow numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor developmentTumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.An Ancient Fecundability-Associated Polymorphism Switches a Repressor into an Enhancer of Endometrial TAP2 Expression.
P2860
Q24676613-F50981BC-F6DB-40B6-A9A1-1C507EF727B6Q26866479-36945B37-B8A3-48DF-BB1B-CDADBE6C0739Q28214433-387DE6AC-8F92-4DD0-BF2E-11DF6FE8CED7Q28295513-9A521C9E-198B-47CC-B207-A64DACC1E15DQ28302676-5B0320A0-8104-4865-81E4-458A0E72EB11Q30374683-19E3DA21-FFF8-4CD4-9E50-AD74C6C9AFB7Q33178945-FE18A01E-C120-4F20-B2CE-6C6627862BCEQ33808144-DFE8BE3C-9A69-4531-9A8C-18AA1F0AE3F1Q33827463-5D8F941E-DAE1-4E50-9AE0-D0776A728A97Q33867072-574DFE4C-8984-4FAA-9CE9-064A7831F3E0Q33942149-E3937C96-139D-4BA0-95AE-17B8896FB1F0Q33998134-2763512E-6F91-4327-8C88-381B4FD66F5BQ34169329-015E12EC-6D88-4690-8931-D96C23258022Q34754320-0DE3E09E-2735-4E9E-AC45-257295C3F899Q34914935-5C1F3C7B-D3F0-4CB6-AC0F-FB38ED18F597Q35041705-4214251A-9331-452D-933C-4B7E5B812BC5Q35045664-CA9CE5F7-9F97-494C-B230-170052B597DFQ35603131-6B5DE296-8CF7-4F0D-B238-D8DCAFF5B53DQ35770325-3E5DA158-297C-4F75-912C-F764242EF307Q35786324-7BA0EA7F-C252-4780-A559-A886AB4133EDQ35899978-04A71993-9C7E-48FD-A8F4-B5397F4BE821Q36081450-B6E8B2E8-EE66-424A-9F6C-9292367A69E2Q36134480-0D748347-2344-4EBD-97B6-D9B47F80AE50Q36151380-2FA171F2-7A9A-45EF-A16F-EE8F872E6E00Q36178994-36CB2270-ABD8-4046-81B8-D50C46CB0684Q36363521-2E1478E0-050A-4190-B50B-559D67607F5DQ36364150-D57AA471-1BE8-4A1D-B891-C908B78AB682Q36364703-EF6ED01C-16F6-45FB-81C1-00DD7232CFFBQ36366222-904CD236-489C-4760-BB57-EC78DF0815DFQ36368364-652C7765-0A5F-437F-90AE-24214D282D35Q36377189-6644CEB7-35EA-477C-BC66-0165E137C47DQ36380506-A81FC74D-5F9A-4FC5-BA00-EFE299A76B9FQ36431817-860ABF53-ADB7-4721-B3FD-AD928B9C47D1Q36470726-FF082252-3865-40FA-9A9E-23D7793AC4BFQ36599550-FD37D9BD-E3F7-4F9C-9069-AEB49A4FDB2BQ36659314-B8B03D17-9C99-439B-A757-01D70D9DC7AAQ37176607-A5B16957-9F9E-4912-A5F6-1F34468CABCFQ37199750-A527AFC0-5392-413E-A753-991F36B0F566Q37360526-85ACEFB0-0F05-497F-B8F2-8C3BC961B824Q37396874-880B41DD-0734-4DD8-A677-54DDA90B18DB
P2860
Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Loss of transporter protein, e ...... ession in cervical carcinomas.
@ast
Loss of transporter protein, e ...... ession in cervical carcinomas.
@en
type
label
Loss of transporter protein, e ...... ession in cervical carcinomas.
@ast
Loss of transporter protein, e ...... ession in cervical carcinomas.
@en
prefLabel
Loss of transporter protein, e ...... ession in cervical carcinomas.
@ast
Loss of transporter protein, e ...... ession in cervical carcinomas.
@en
P2093
P2860
P356
P1476
Loss of transporter protein, e ...... ression in cervical carcinomas
@en
P2093
C J Meijer
F V Cromme
H L Ploegh
J M Walboomers
P J Keating
P2860
P304
P356
10.1084/JEM.179.1.335
P407
P577
1994-01-01T00:00:00Z